Isolation and pharmacological characterisation of hostoxin-1, a postsynaptic neurotoxin from the venom of the Stephen's banded snake (Hoplocephalus stephensi)

Neuropharmacology

Volumn 51, Issue 4, 2006, Pages 782-788

  Tan, Li C ^a   Kuruppu, Sanjaya ^a   Smith, A Ian ^a   Reeve, Shane ^a   Hodgson, Wayne C ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antivenom; Chromatography; Neurotoxin; Nicotinic receptor; Skeletal muscle; Snake venom

Indexed keywords

ACETYLCHOLINE; CARBACHOL; HOSTOXIN 1; NEUROTOXIN; NICOTINIC RECEPTOR; PHOSPHOLIPASE A2; POTASSIUM CHLORIDE; SNAKE VENOM; SNAKE VENOM ANTISERUM; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CHICK; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; MUSCLE TWITCH; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SKELETAL MUSCLE; SNAKE; STATISTICAL SIGNIFICANCE;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANOPLURA; CARBACHOL; CHICKENS; CHOLINERGIC AGONISTS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ELAPID VENOMS; MOLECULAR WEIGHT; MUSCLE CONTRACTION; NEUROMUSCULAR JUNCTION; NEUROTOXINS; PHOSPHOLIPASES A; SEQUENCE ANALYSIS, PROTEIN; SNAKE VENOMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 33747834965     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.05.020     Document Type: Article

References (22)

1. Anderson A.J., Harvey A.L., and Mbugua P.M. Effects of fasciculin 2, an anticholinesterase polypeptide from green mamba venom, on neuromuscular transmission in mouse diaphragm preparations. Neurosci. Lett. 54 (1985) 123-128
2. Broad A.J., Sutherland S.K., and Coulter A.R. The lethality in mice of dangerous Australian and other snake venoms. Toxicon 17 (1979) 661-664
3. Christopoulos A., Coles P., Lay L., Lew M.J., and Angus J.A. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens. Br. J. Pharmacol. 132 (2001) 1281-1291
4. Christopoulos A., Parsons A.M., Lew M.J., and El-Fakahany E.E. The assessment of antagonist potency under conditions of transient response kinetics. Eur. J. Pharmacol. 382 (1999) 217-227
5. Comadira G.P., and Green D. Three cases of envenomation by Stephen's banded snakes. Emerg. Med. 7 (1995) 15-18
6. Currie B. A prospective study of snakebite in tropical Australia. Aust. N.Z. J. Med. 29 (1999) 602
7. Endo T., and Tamiya N. Structure-function relationships of postsynaptic neurotoxins from snake venoms. In: Harvey A.L. (Ed). Structure-Function Relationships of Postsynaptic Neurotoxins from Snake Venoms (1991), Pergamon Press, New York 165-222
8. Fry B.G. Structure-function properties of venom components from Australian elapids. Toxicon 37 (1999) 11-32
9. Harvey A.L., Barfaraz A., Thomson E., Faiz A., Preston S., and Harris J.B. Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro preparations from rodents and chicks. Toxicon 32 (1994) 257-265
10. Hodgson W.C., Eriksson C.O., Alewood P.F., and Fry B.G. Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): efficacy of tiger snake antivenom. Clin. Exp. Pharmacol. Physiol. 30 (2003) 127-132
11. Hodgson W.C., and Wickramaratna J.C. The in vitro neuromuscular activity of snake venoms. Clin. Exp. Pharmacol. Physiol. 29 (2002) 807-814
12. Kim H.S., and Tamiya N. Isolation, properties and amino acid sequence of a long-chain neurotoxin, Acanthophis antarcticus b, from the venom of an Australian snake (the common death adder, Acanthophis antarcticus). Biochem. J. 193 (1981) 899-906
13. Kuruppu S., Reeve S., Smith A.I., and Hodgson W.C. Isolation and pharmacological characterisation of papuantoxin-1, a postsynaptic neurotoxin from the venom of the Papuan black snake (Pseudechis papuanus). Biochem. Pharmacol. 70 (2005) 794-800
14. Lew M.J., and Angus J.A. Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol. Sci. 16 (1995) 328-337
15. Nirthanan S., Charpantier E., Gopalakrishnakone P., Gwee M.C., Khoo H.E., Cheah L.S., Bertrand D., and Kini R.M. Candoxin, a novel toxin from Bungarus candidus, is a reversible antagonist of muscle (αβγδ) but a poorly reversible antagonist of neuronal α7 nicotinic acetylcholine receptors. J. Biol. Chem. 277 (2002) 17811-17820
16. Rao V.S., Joseph J.S., and Kini R.M. Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa. Biochem. J. 369 (2003) 635-642
17. Sutherland S.K., and Tibballs J. Australian Animal Toxins: The Creatures, Their Toxins and Care of the Poisoned Patient. second ed. (2001), Oxford University Press, Melbourne
18. Takasaki C., and Tamiya N. Isolation and amino acid sequence of a short-chain neurotoxin from an Australian elapid snake, Pseudechis australis. Biochem. J. 232 (1985) 367-371
19. Tyler M.I., Retson-Yip K.V., Gibson M.K., Barnett D., Howe E., Stocklin R., Turnbull R.K., Kuchel T., and Mirtschin P. Isolation and amino acid sequence of a new long-chain neurotoxin with two chromatographic isoforms (Aa e1 and Ae e2) from the venom of the Australian death adder (Acanthophis antarcticus). Toxicon 35 (1997) 555-562
20. White J. CSL Antivenom Handbook (2001), CSL Ltd, Melbourne 69 pp.
21. Wickramaratna J.C., Fry B.G., Loiacono R.E., Aguilar M.I., Alewood P.F., and Hodgson W.C. Isolation and characterization at cholinergic nicotinic receptors of a neurotoxin from the venom of the Acanthophis sp. Seram death adder. Biochem. Pharmacol. 68 (2004) 383-394
22. Zamudio F., Wolf K.M., Martin B.M., Possani L.D., and Chiappinelli V.A. Two novel alpha-neurotoxins isolated from the taipan snake, Oxyuranus scutellatus, exhibit reduced affinity for nicotinic acetylcholine receptors in brain and skeletal muscle. Biochemistry 35 (1996) 7910-7916